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Resistance to azole antifungals is a major problem in the control
of diseases caused by fungal pathogens of both humans and
plants. Potential for the development of azole resistance in the





causal agent of the most economically significant foliar disease
of wheat in north-western Europe, is now of particular concern
after the recent emergence of widespread resistance to quinone
outside inhibitor fungicides. Using a cDNA microarray represent-
ing around 25% of the genome, we have profiled the transcrip-




 to epoxiconazole, currently the
most widely used azole fungicide on cereal crops. By comparing





contrasting sensitivities to epoxiconazole we show qualitative
and quantitative differences in differentially expressed genes,
including those involved in ergosterol biosynthesis, mitochondrial
respiration and transport mechanisms. This represents the first
study investigating the response of a plant pathogenic fungus to
 













) has been the
most economically important fungal pathogen of winter wheat in
the UK for over 20 years, causing estimated yield losses of £30




., 2001). None of the current
commercially available wheat cultivars is fully resistant to the
disease. Therefore, the programmed application of fungicides is the
only effective control strategy. Groups of site-specific systemic
fungicides including the methyl benzimidazole carbamates (MBCs),
quinone outside inhibitors (QoIs) and demethylation inhibitors
(DMIs) have been used extensively against the disease since the
early 1970s. However, the pathogen has quickly adapted and
resistance to a number of chemical classes, including the MBCs





2003, 2005). Resistance to the azole group of DMI fungicides has
not yet emerged. However, owing to the current lack of alternative
chemistry to control the disease, and the consequent increased
reliance on azoles, there is concern that resistance to this group
could develop, particularly in light of the recent decline in efficacy
of a range of azoles in controlling Septoria leaf blotch (Clark,
2006).
Azole resistance in plant pathogenic fungi has previously
developed slowly and loss of efficacy in practice remains rare. By
contrast, resistance to azoles in human pathogens is a major
problem, particularly in immunosuppressed patients in whom





, is commonly compromised by
resistance. The adaptation of human fungal pathogens to azoles
demonstrates the biological potential for resistance develop-
ment, thereby providing a paradigm for the evolution to resist-
ance in other pathogens, including those of plants. Consequently,
studies of the mechanisms underlying changes in azole sensitivity
in plant pathogens have to date focused on those well-characterized









 is up-regulation of active efflux proteins, ATP-binding
cassette (ABC) transporters and major facilitators (MFs), which




., 2001). Active efflux has also been shown to contribute to
azole resistance in plant pathogens, although identified most





 resistant to azoles with altered expression of
ABC transporter genes have been shown to revert to an azole-





., 2002). Efflux pump over-expression has only been












field isolates collected in the 1990s showed differences in both
basal and induced levels of ABC transporter gene transcript,
although no correlation between increased expression and azole


































(5 ) , 639–651 © 2007 BLACKWELL  PUBL ISH ING LTD
 
failed to establish any direct relationship between over-expression





the contribution of active efflux to azole resistance in field
populations of plant pathogens, although implicated, remains
unclear.
The most common mechanism of resistance to site-specific
fungicides is modification of the target protein. The target for





(CYP51), an essential enzyme of the ergosterol biosynthesis
pathway, the predominant sterol in the membranes of fungi.
Alterations in CYP51 have been associated with changes in azole
sensitivity in fungal pathogens of humans and plants, although



























 encoding changes at





 have also been identified in plant
pathogens, most notably the equivalent to substitution Y132F/H




., 1997, 1998; Wyand and Brown,








., 2005b). Our studies have also identified
CYP51 alterations not previously associated with azole resistance
in human or plant pathogenic fungi. Substitution I381V, for example,
appears to be differentially selected by members of the azole class












 mutations confer greater reductions in azole sensitivity
than single mutations. In plant pathogens mutations also appear

























 mutations can have different azole sensitivities, the exact
impact of target site changes on azole efficacy in the field





In this study, we have used cDNA microarrays to profile the




 to epoxiconazole, cur-
rently the azole most widely used to control this disease. We have





 isolate to a single discriminatory dose to
determine whether decreased azole sensitivity is conferred by




 gene. To our
knowledge, this is the first investigation into the response of a
plant pathogenic fungus to a fungicide using microarrays. We
describe the effect of epoxiconazole treatment on genes involved
in ergosterol biosynthesis, mitochondrial respiration and toxicant
transport. Furthermore, we report both qualitative and quantita-








 mutations and con-










 to epoxiconazole for isolate G303 is around










2005b), with a number of encoded amino acid changes identified
in G303. Some of these alterations have been correlated with













 values for Rothamsted, Hertfordshire, isolates
obtained in 2006 ranged from 0.164 mg/L (isolate R6-40) to




 mutations were identified in






Constitutive differences in gene expression between 
IPO323 and G303
 
Ten genes were more highly expressed, beyond a two-fold cut off,
in less sensitive isolate G303 compared with sensitive isolate
IPO323 (Table 2). These include those encoding a drug transporter
(unisequence Id: mga1012f) protein, a cell surface glycoprotein
(mg[0175]), thought to be a flocculin, stress response protein




-inositol transport protein (mgb17a02f),
a mitochondrial transport protein (mgb12c11f), and an unknown






Table 1 M. graminicola isolates used in this study.
Isolate Year Location
Epoxiconazole 
EC50 (mg/L) CYP51 alteration(s)
IPO323 1981 Netherlands 0.06 none
G303 2003 Kent 1.47 L50S, D138G, S188N, A379G, I381V, ∆Y459-G460, N513K
R6-31 2006 Hertfordshire 2.19 Y137F
R6-32 2006 Hertfordshire 0.698 L50S, S188N, I381V, ∆Y459-G460, N513K
R6-40 2006 Hertfordshire 0.164 L50S, I381V, Y459D
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Gene expression in response to epoxiconazole 
treatment
 
Genes up-regulated in response to 24 h exposure to a lethal
(Table 1) dose of epoxiconazole in isolate IPO323, beyond a two-
fold cut-off, all encoded components of the sterol biosynthesis



























isolate G303 also increased after treatment with a non-lethal
(Table 1) dose of epoxiconazole, although transcript levels were
lower than those detected for IPO323 (Table 4). Furthermore,





), an enzyme involved in mevalonate synthesis,
a precursor of ergosterol biosynthesis, is up-regulated in G303.









., 2001). Genes other than those encoding proteins
involved in sterol biosynthesis up-regulated in G303 include a
putative hexose transporter, mg[0271], a ubiquinol cytochrome c
reductase subunit, mg[1446], and an unknown protein homolo-






Hierarchical clustering of genes involved in sterol 
biosynthesis
 
Hierarchical clustering of genes in the same functional category
(MIPS) associated genes by relative expression profile. This
enabled genes that were not differentially expressed beyond
the stringent two-fold cut-off to be analysed. Cluster analysis












 (mg[0869]) as up-regulated in response to
24 h epoxiconazole treatment (Fig. 1A). In addition, expression
of genes encoding a sterol isomerase (mga1231f) and the sterol
C-24 reductase (mgc19a12f) were identified by clustering as
azole induced. Expression of mgc19a12f, encoding erg4, the
sterol C-24 reductase, is only induced in G303, perhaps reflecting
continued ergosterol production in this isolate. Genes originally
annotated as involved in sterol biosynthesis that are unaffected
or down-regulated by azole treatment include mg[1270] encoding
a farnesyl diphosphate synthetase (erg20), mg[0650] suggested
to encode the sterol C-24 methyltransferase (erg6) and other sterol-
associated proteins, for example mg1265f encoding a hydroxys-
teroid dehydrogenase. However, Blastx searches fail to identify
Table 2 Genes differentially expressed in isolate G303 compared with isolate IPO323 in the absence of epoxiconazole.
Functional category (MIPS) EST ID
Unisequence 




cell wall biogenesis mga0371 mga0371 N-acetyl-β-D-glucosaminidase (exochitinase); AAL78815 +2.1
drug transporters mga1012f mga1012f multidrug resistance protein; EAA28910 +3.4
electron transport proteins mga0964 mga0964 subunit IV of cytochrome c oxidase; EAA33815 +2.1
mitochondrial transport mgb12c11f mgb12c11f protein of the inner mitochondrial membrane, required 
for import of mitochondrial matrix proteins; EAA36389
+2.4
organization of cell wall mga0959f mg[0175] cell surface flocculin (glycoprotein); T45462 +3.4
mgc02g01f mg[0558] homologue of clock controlled protein 6 
(N. crassa) (cell surface glycoprotein); Q01302
+2.1
protein modification mg12h01f mg12h01f nuclear protein arginine methyltransferase; EAA34674 +2.1
sugar, carbohydrate and 
metabolite transporters
mgb17a02f mgb17a02f myo-inositol transport protein; EAA28903 +2.6
stress response mga0334 mg[0194] stress response protein (rds1); CAD21425 +3.2
unclassified protein mgc03e06f mg[1000] homologue of CipA (E. nidulans), associated 
with antibiotic response; CAC87270
+2.8
*Sequences available at http://cogeme.ex.ac.uk/
Table 3 Genes differentially expressed in isolate IPO323 after 24 h exposure to 2 mg/L epoxiconazole.
Functional category 
(MIPS) EST ID Unisequence ID* Best match; accession no.
Mean fold change 
in expression
tetracyclic and pentacyclic mgc01h02f mg[0887] C-4 sterol methyl oxidase; EAA33004 +4.2
triterpene (steroids and 
hopanoids) biosynthesis
mga0888f mga0888f C14-sterol reductase; O13597 +7.7
mgc01f02f mg[0869] sterol C-22 desaturase; BAC01140 +5.9
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Fig. 1 Hierarchical clustering showing the 
patterns of expression of genes involved in sterol 
biosynthesis (A) and electron transport (B) in 
isolate IPO323 after 1 h (IPO 1) and 24 h (IPO 24) 
and G303 after 1 h (G3 1) and 24 h (G3 24) of 
epoxiconazole treatment. Colour bars display 
normalized log2 (green/red) ratio, with untreated 
IPO323 as the reference point. EST IDs are shown. 
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most of these genes (mga1265, mg[0216], mgb16g02f and
mgb0245f) as sterol-associated. The exceptions are mg[1270],



















Hierarchical clustering of genes encoding components 
of the mitochondrial electron transport chain
 
Clustering of genes encoding components of the mitochondrial
electron transport chain revealed a number up-regulated in
response to epoxiconazole (on average around 1.5-fold),
particularly in isolate IPO323 (Fig. 1B). Interestingly, most azole-
responsive genes are mitochondrially encoded. For example, sub-
units 1–7 of the NADH-ubiquinone oxidoreductase complex are
mitochondrially encoded in fungi and higher eukaryotes. All of
these represented on the microarray (subunits 1 (mg[0372]), 2
(mg[0201]; mga0891f), 4 (mga1866f; mga2093f) and 5 (mga0805f))
are up-regulated in response to epoxiconazole treatment. The
remaining NADH-ubiquinone oxidoreductase subunits are nuclear
encoded. These include the 51-kDa (mg[1340]), 78-kDa (mga[0489])
and 20.8-kDa (mgc02a12f) subunits, all either unaffected or





and subunit III of the cytochrome c oxidase (mg[0306]) are
mitochondrially encoded, with smaller subunits (e.g. subunit V
(mgc14d12f), VI (mga1848f)) encoded in the nucleus.
 
Validation of microarray data by quantitative RT-PCR 
and analysis of Rothamsted 2006 isolates
 
Genes selected for analysis by quantitative RT-PCR were those
either constitutively up-regulated in isolate G303 (mga1012f
(Fig. 2A) and mg[0194] (Fig. 2B)), involved in sterol biosynthesis




 azole target (Fig. 2D),
absent from the microarray) and responsive to epoxiconazole,
but not directly involved in sterol biosynthesis (mg[0271]
(Fig. 2E) and mgc03g08f (Fig. 2F)). In general, quantitative RT-
PCR results correlated well with microarray data, although for
some genes, particularly mga0888f, fold changes in expression
were greater, perhaps reflecting the greater dynamic range of
real-time PCR.
Analysis of the expression of mg1012f (Fig. 3A) and epoxico-
nazole-responsive genes mg[0271] (Fig. 3B) and mgc03g08f




 isolates with varying azole sensitivi-
ties obtained from an untreated field at Rothamsted in 2006
revealed differences in constitutive and azole-induced transcript
levels between isolates. For example, a high basal level of mga1012f
expression was only detected in R6-55, with expression slightly
reduced after epoxiconazole treatment, similar to results for
G303. In the remaining isolates mga1012f expression was gen-
erally unaffected by azole. Expression of mg[0271] was induced
by epoxiconazole treatment in all isolates; however, transcript
levels varied between isolates with highest basal (6.2-fold) and
induced (9.8-fold) expression levels detected for the least sensi-
tive isolate R6-31. Mean expression levels of mgc03g08f, the
predicted iron/ascorbate oxidoreductase gene, varied greatly
between isolates. A 53-fold increase (relative to the calibrator
sample) in transcript level was detected after epoxiconazole
treatment in isolate R6-55. In no other isolates was mgc03g08f




Microarray transcriptional profiling of the response of human
fungal pathogens to antifungals has already proved successful
in identifying novel genes and/or gene families expressed upon
exposure to these compounds and involved in the acquisition of








., 2006; Rogers and
Barker, 2003). This is the first study using microarray technology
to profile the response of a plant pathogen when exposed to a
fungicide. By analysing the expression of expressed sequence
Table 4 Genes differentially regulated in isolate G303 after 24 h exposure to 2 mg/L epoxiconazole.
Functional category (MIPS) EST ID
Unisequence 




electron transport proteins mgb12h11f mg[1446] ubiquinol cytochrome-c reductase subunit; P48503 +2.1
isoprenoid biosynthesis mga1391f mga1391f hydroxymethylglutaryl-CoA synthase, 
functions in mevalonate synthesis; T49718
+2.2
sugar, carbohydrate and metabolite transporters mgb0930f mg[0271] hexose transporter; EAA28833 +2.1
tetracyclic and pentacyclic triterpene 
(steroids and hopanoids) biosynthesis
mgc01h02f mg[0887] C-4 sterol methyl oxidase; EAA33004 +2.9
mga0888f mga0888f C14-sterol reductase; O13597 +3.6
mgc01f02f mg[0869] sterol C-22 desaturase; BAC01140 +4.5
unclassified protein mgc03g08f mgc03g08f homologue of FAO1 (Cryptococcus neoformans); AAN75712 +2.8
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tags (ESTs), predicted to cover a quarter of the genome of the




, upon exposure to
the azole fungicide epoxiconazole, we have confirmed the effect
of this compound on ergosterol biosynthesis, and, in addition,
demonstrated an impact on the expression of components of the
respiratory chain, predominantly those encoded in the mitochon-
drial genome. Comparison of the expression profile of an isolate





 gene, with the sensitive isolate (IPO323), both
in the absence and in the presence of epoxiconazole, has identi-
fied differentially expressed genes that potentially have a role in
reducing azole sensitivity in G303. Subsequent quantitative RT-
PCR analyses of the expression of these candidate genes in four
more recently collected isolates with varying levels of azole sen-
sitivity suggest these genes may also contribute to a less sensitive






Response of genes involved in ergosterol biosynthesis
 
Genes encoding components of the ergosterol biosynthesis path-
way that are represented on the microarray were consistently the
most responsive to treatment, confirming that this pathway is the
primary target for epoxiconazole and responds to changes in
ergosterol levels. Most ergosterol biosynthesis genes were up-















 (mg[0650]), encoding the sterol C-24 meth-









by azole treatment in isolate IPO323 and decreased in G303.
The sterol C-24 reductase catalyses the final step in ergosterol
biosynthesis. Therefore, differential expression of erg4 between
isolates in the presence of epoxiconazole may reflect differences
in the capacity of isolates to complete ergosterol biosynthesis.
Consistent with this study, expression of erg20 is not affected by
azole treatment in Saccharomyces cerevisiae (Bammert & Fostel
2000) and C. albicans (De Backer et al., 2001). The observed
effect of epoxiconazole treatment on erg6 expression, however,
conflicts with previous studies of both S. cerevisiae (Agarwal
et al., 2003; Bammert & Fostel, 2000) and C. albicans (De Backer
et al., 2001). This discrepancy with earlier studies and other data
presented here, particularly the up-regulation of erg5, erg24 and
Fig. 2 Validation of microarray results using 
quantitative RT-PCR for genes identified as 
differentially expressed in microarray experiments. 
Shown are relative expression values in untreated 
IPO323 (IPO323 Un) and after 24 h of 
epoxiconazole treatment (IPO323 Ep) and 
untreated G303 (G303 Un) and after 24 h of 
epoxiconazole treatment (G303 Ep). Unisequences 
IDs of genes analysed are mga1012f (A), mg[0194] 
(B), CYP51/erg11 (C, not represented on the 
microarray), mga0888f (D), mg[0271] (E) and 
mg03g08f (F). Mean of two replicate experiments 
with standard deviations are shown.
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erg25 in response to azole, suggests this gene may not be
correctly annotated and requires further analysis to establish its
precise function. In Aspergillus fumigatus, the only filamentous
fungus to be analysed after antifungal treatment by microarray
thus far, expression of erg24 and erg25 also increased upon expo-
sure to voriconazole (Ferreira et al., 2006), although unlike this
(as shown by quantitative RT-PCR) and other studies (Agarwal
et al., 2003; De Backer et al., 2001; Liu et al., 2005) expression of
both CYP51/erg11 paralogues in A. fumigatus decreased upon
treatment. Amongst the remaining genes predicted to encode
components of the ergosterol biosyntheisis pathway, EST mga1231f,
suggested to encode a sterol isomerase, is up-regulated upon
azole exposure. Although homology searches suggest this gene
does not encode erg2, evidence here does suggest mga1231f
responds to changes in ergosterol levels.
The mechanisms responsible for erg gene up-regulation upon
azole exposure remain unclear. However, consistent with other
studies of S. cerevisiae (Agarwal et al., 2003; Bammert and
Fostel, 2000) and C. albicans (De Backer et al., 2001; Liu et al.,
2005), greatest changes in gene expression levels in M. graminicola
after azole treatment were detected for genes encoding compo-
nents functioning downstream of CYP51/erg11 (Fig. 4). This
suggests that erg gene expression is induced specifically by
ergosterol depletion, as has previously been proposed (Agarwal
et al., 2003; De Backer et al., 2001; Liu et al., 2005). Alteration of
erg gene expression, particularly up-regulation of erg11/CYP51,
has been shown to confer azole resistance both in human (Rogers
and Barker, 2003; White, 1997) and in plant pathogenic fungi
(Hamamoto et al., 2000; Schnabel and Jones, 2001). In this study,
no constitutive differences in erg gene expression were evident
in microarray studies when the less sensitive isolate G303 was
compared with the sensitive isolate IPO323. After 24 h exposure
to azole, levels of erg gene up-regulation were similar between
isolates. Quantitative RT-PCR analysis did suggest some differences
in basal erg11/CYP51 and erg24 transcript levels. For example,
erg11/CYP51 expression appeared around two-fold higher in
G303. However, in the absence of corroborative microarray data,
it is difficult to conclude an impact of altered erg gene expression
on reducing azole sensitivity in G303.
Response of genes involved in mitochondrial 
electron transport
The relationship between ergosterol biosynthesis and mitochon-
drial respiration has long been established. For example, certain
steps of ergosterol biosynthesis are dependent on mitochondrial
development in yeast (Daum et al., 1998). Yet the effect of azoles
on mitochondrial function is not clearly defined. In this study,
hierarchical clustering revealed that a number of genes encoding
components of the mitochondrial electron transport chain were
up-regulated (between 1.5- and 1.8-fold) by epoxiconazole
treatment. Microarray and erg mutant studies of S. cerevisiae
(Bammert and Fostel, 2000) also demonstrated increased tran-
script levels of respiratory chain components after azole treatment,
including members of the cytochrome c oxidase and cytochrome
c reductase complexes and subunits of ATP synthase. Unlike the
Fig. 3 Quantitative RT-PCR analysis of the expression of mga1012f (A), 
mg[0271] (B) and mgc03g08f (C) in isolates obtained from Rothamsted, 
Hertfordshire, in 2006 (R6-31, R6-32, R6-40 and R6-55). Expression analyses 
were carried out on untreated (filled) and 24 h epoxiconazole-treated (shaded) 
samples using untreated IPO323 as the reference. Mean of two replicate 
experiments and standard deviations are shown. For clarity, a break (10–50) 
has been inserted into the y-axis of graph C.
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findings presented here, however, Bammert and Fostel (2000)
also observed increased transcript levels of known oxidative stress
response genes, leading to the suggestion that perturbation of
ergosterol biosynthesis by mutation or azole, and the consequent
accumulation of sterol precursors, indirectly affects mitochondrial
electron transport, leading to the generation of reactive oxygen
species (ROS). Other microarray studies of fungi including C. albicans
and A. fumigatus have not observed changes in electron transport
gene expression upon azole exposure; however, studies of the
transcriptional response of the bacterial pathogen Mycobacterium
tuberculosis to azole treatment did identify responsive compo-
nents of the respiratory chain (Boshoff et al., 2004).
Studies of petite mutants of S. cerevisiae and Candida glabrata
provide additional evidence for an interaction between azole
and mitochondria. In both S. cerevisiae (Kenna et al., 1989) and
C. glabrata (Sanglard et al., 2001) azoles have been shown to be
potent inducers of petite mutagenesis and, furthermore,
petite mutants are highly resistant to azoles (Brun et al., 2004;
Sanglard et al., 2001). Brun et al. (2004) suggested that azoles
induce petite mutagenesis by directly inhibiting mitochondrial
function, causing an accumulation of ROS and leading to
mitochondrial damage. A direct interaction of azoles with
components of the respiratory chain has previously been
demonstrated using isolated mitochondria from C. albicans
(Shigematsu et al., 1982).
Interestingly, most of the components of the respiratory chain
which were up-regulated in response to epoxiconazole treatment
in this study are mitochondrially encoded. The exceptions are
the nuclear encoded NADH-ubiquinone oxidoreductase 49-kDa
(mga1968) subunit and cytochrome c reductase subunit VII
(mg[1446]), both of which are only responsive in isolate G303.
Therefore, consistent with previous studies, epoxiconazole treat-
ment of M. graminicola induces the expression of genes involved
in mitochondrial respiration (Bammert and Fostel, 2000; Boshoff
et al., 2004); however, it remains to be investigated whether this
induction is specific to mitochondrially encoded components of
the respiratory chain.
Response of genes encoding transporter proteins
In this study, only two genes encoding transport proteins were
differentially expressed between isolates, or induced upon epox-
iconazole treatment. mga1012f, encoding a vacuolar glutathione
S-conjugate ABC transporter, potentially involved in drug
resistance, is constitutively over-expressed in isolate G303.
Upon epoxiconazole exposure, however, expression of this gene
decreases in this isolate, suggesting this gene is not contributing
to reducing azole sensitivity in G303. Homology searches against
the fungal genome database identify mga1012f as a vacuolar
glutathione S-conjugate ABC transporter. These proteins are
members of the multidrug resistance-related family of ABC
transporters, primarily involved in the detoxification of metals
(De Waard et al., 2006). No transporters of this type have previ-
ously been associated with altered azole sensitivity, although
Fig. 4 Schematic of the ergosterol biosynthesis 
pathway from farnesyl pyrophosphate. Genes 
represented on the microarray are shown in 
bold type.
M. graminicola transcriptome in response to azole 647
© 2007 BLACKWELL  PUBL ISH ING LTD MOLECULAR PLANT PATHOLOGY (2007)  8 (5 ) , 639–651
coexpression of an ABC transporter and a glutathione-S-
transferase gene has been suggested to be involved in voriconazole
detoxification in A. fumigatus (Ferreira et al., 2006).
Microarray analysis demonstrated increased expression of
mg[0271], encoding a putative hexose transporter, upon epoxi-
conazole treatment in G303. Expression of this gene was also
shown subsequently by quantitative RT-PCR to be induced in
isolate IPO323, although not to the same extent (around two-
fold in IPO323 compared with six-fold in G303). Expression of
this gene in four more recently obtained M. graminicola isolates
appears to be similarly affected by azole treatment. Interestingly,
the highest constitutive and induced transcript levels of mg[0271]
were detected in the least sensitive isolate R6-31. Hexose trans-
porters of the major facilitator superfamily have been previously
implicated in resistance to drugs. D-Hexose transporters have
been shown to modulate drug accumulation in Xenopus oocytes
expressing murine Mdr1b, an ABC transporter that confers a
multidrug-resistant phenotype (Vera et al., 1991). HXT9 and HXT11,
two S. cerevisiae hexose transporter genes that have homology
to mg[0271] (5e-12), have also been implicated in a multidrug-
resistant phenotype (Nourani et al., 1997). Both HXT9 and HXT11
are Pdr1p and Pdr3p targets, transcriptional regulators of ABC
transporters required for drug resistance in yeast. Interestingly,
although HXT9 and HXT11 are co-regulated with multidrug
transporter genes, deletion of either gene decreases sensitivity to
drugs, and, conversely, over-expression of HXT11 increases sen-
sitivity, leading to the suggestion that these proteins are not
involved in drug efflux per se, but rather in modulating membrane
permeability in cells which are over-expressing drug efflux ABC
transporters (Nourani et al., 1997).
Thirteen genes encoding toxicant efflux proteins, predomi-
nantly ABC transporters and MF proteins, are present on this
M. graminicola microarray. The lack of transporters identified as
azole-responsive in this study is therefore somewhat surprising.
However, previous microarray studies of the transcriptional response
of S. cerevisiae (Bammert and Fostel, 2000) and C. albicans (De
Backer et al., 2001) to azoles have also failed to detect significant
up-regulation of efflux proteins. This is in contrast to earlier can-
didate gene approaches [e.g. the identification of CDR1 induction
in response to fluconazole in C. albicans (Hernaez et al., 1998)].
Kontoyiannis and May (2001) suggested conditions of microarray
studies, such as azole concentration and exposure time, were not
optimal for detection of transporter gene expression. This might
also apply to the current study, as only a single time point at a sin-
gle fungicide concentration has been studied in detail. However,
if a transporter is directly involved in exporting epoxiconazole out
of the M. graminiola cell, it may simply be that it is not repre-
sented on this microarray. Up-regulation of hexose transporter
(mg[0271]) in response to azole treatment in isolates with great-
est reductions in azole sensitivity provides evidence for this, as
studies have suggested that homologues of mg[0271] are involved
in regulating membrane permeability in S. cerevisiae cells over-
expressing efflux pumps (Nourani et al., 1997).
Response of other genes
Azole resistance, for example in C. albicans, has been shown in
both candidate gene (White, 1997) and microarray (Rogers and
Barker, 2003) studies to be conferred, at least in part, by the con-
stitutive over-expression of genes in resistant isolates. In this
study, the expression of all genes identified as constitutively up-
regulated in less sensitive isolate G303, for example mg[0194]
and mgc03e06f, decreased upon epoxiconazole treatment. It
seems unlikely therefore that these genes play a role in reducing
azole sensitivity in G303, although they may confer an improved
capacity of this isolate to compete, infect and reproduce com-
pared with the sensitive isolate IPO323. For example, mg[0194]
is a homologue of the yeast stress response protein rds1 (Ludin
et al., 1995). This gene has been shown to be highly expressed in
pycnidiospores and late-stage in planta infection in M. graminicola
isolate IPO323, but not in vitro, suggesting a specific role for this
gene in reproduction and infection (Keon et al., 2005a,b). EST
mgc03e06f encodes a homologue of the antibiotic response
protein CipA of A. nidulans. CipA expression in A. nidulans is
responsive to concanamycin A produced by Streptomyces (Melin
et al., 2002). Therefore, the product of mgc03e06f may also
afford M. graminicola protection against antibiotics produced by
antagonistic microorganisms in the wheat phylloplane.
Microarray analyses identified one unclassified gene, mgc03g08f,
as azole induced in G303. None were detected in studies of
IPO323. This gene is annotated as a homologue of a C. neoformans
mating-type locus marker, FAO1 (Lengeler et al., 2002), and
has high homology to an iron/ascorbate oxidoreductase from
A. fumigatus. Very high transcript levels of this gene (greater
than 50-fold increase) were also detected in the less sensitive iso-
late R6-55 after epoxiconazole treatment. No members of this
protein family have previously been associated with response to
azole in studies of fungal pathogens. In plants, these proteins
have been suggested to play a role in detoxifying ROS (Qiu et al.,
2004). Consistent with an effect of epoxiconazole on components of
the mitochondrial respiratory chain, induction of mgc03g08f may
be in response to changing the oxidative state of the cell. Further
functional studies are required to determine the exact impact of
the product of this gene on azole sensitivity.
CONCLUSIONS
Profiling the response of M. graminicola to epoxiconazole using
a cDNA microarray representing around one-quarter of the
genome has confirmed ergosterol biosynthesis as the primary
target of this compound and, furthermore, demonstrated an
additional effect on components of the mitochondrial respiratory
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chain. The findings presented here are, in general, consistent with
previous studies of the response of fungi to azoles. The reported
anomalies, for example down-regulation of a putative erg6 gene
after azole treatment, are most probably a consequence of
misannotation of the EST set. The forthcoming release of the
M. graminicola annotated genome sequence should resolve these
inconsistencies. Comparisons of constitutive and azole-induced
expression profiles between an azole-sensitive and less sensitive
isolate failed to identify a gene, for example a drug efflux protein,
directly responsible for the reduced azole sensitivity phenotype.
However, a gene encoding a hexose transporter has been shown
to be more highly expressed in least sensitive isolates. Although
probably not directly involved in azole efflux, this protein may
modulate the membrane activity of isolates over-expressing an,
as yet unidentified, efflux protein. In the future, studies using whole
genome microarrays will facilitate the identification of genes,
and therefore mechanisms (other than target site alteration)
responsible for decreased azole sensitivity in M. graminicola.
EXPERIMENTAL PROCEDURES
Fungal isolates
M. graminicola isolates G303, R6-31, R6-32, R6-40 and R6-55
(Table 1) were obtained following the protocol described in Fraaije
et al. (2007). Briefly, wheat leaves with lesions were stapled on
to sterile moist filter paper, placed in up-turned Petri dishes and
incubated overnight at 23 °C. Single cirri, emerging from pycnidia,
were collected using sterile forceps and suspended in 30 µL of
sterile distilled water. Suspensions were streaked on to yeast potato
dextrose agar (YPD; ForMedium, Norwich, UK) amended with
penicillin G sodium and streptomycin sulphate at 100 µg/mL and
incubated for 5 days at 23 °C. Single colonies grew in the form of
yeast-like budding cells. Single spore isolates were propagated by
transferring single colonies to fresh YPD plates. Isolates were stored
in 80% glycerol at –80 °C until epoxiconazole sensitivity testing.
Epoxiconazole sensitivity testing
Sensitivity assays were also according to Fraaije et al. (2007),
with a few modifications. One hundred microlitres of 2× potato
dextrose broth (PDB; Sigma-Aldrich, Inc., St. Louis, MO) amended
with decreasing concentrations of epoxiconazole (30, 10, 3.3,
1.1, 0.37, 0.123, 0.041, 0.014, 0.005, 0.0015 and 0.0005 mg/L)
was added to wells of flat-bottomed microtitre plates (TPP 92696
test plates, Trasadingen, Switzerland). After 7 days’ growth at 15 °C
on YPD to ensure yeast-like growth, isolates were suspended in
5 mL sterile distilled water. Aliquots of 100 µL of isolate spore
suspensions (1 × 105 spores/mL) were added to each well. Plates
were incubated for 4 days at 23 °C, and growth measured by
absorbance at 630 nm using an MRX plate reader (Dynex Tech-
nologies, Chantilly, VA). Fungicide sensitivities were determined
as 50% effective concentration (EC50) using a dose–response
relationship (Table 1).
CYP51 sequencing
CYP51 genes of M. gramincola isolates IPO323, G303, R6-31,
R6-32, R6-40 and R6-55 were amplified and sequenced using
the primers, PCR conditions and protocols outlined in Cools et al.
(2005a). Amplifications were carried out using Phusion high-
fidelity DNA polymerase to ensure the validity of sequences
(Finnzymes, Espoo, Finland).
Growth of fungal cultures for microarray and 
quantitative RT-PCR analyses
M. graminicola isolate spore suspensions were added to 100 mL
of PDB (Sigma) at a final concentration of 4 × 105 spores/mL. Cul-
tures were grown at 23 °C with shaking (220 r.p.m.). After 48 h,
with isolates in the linear phase of growth (data not shown),
epoxiconazole was added to each culture at 2 mg/L, a concen-
tration lethal to isolate IPO323 and around 50% effective (EC50)
for isolate G303. Isolate IPO323 has previously been treated at
the approximate EC50 (0.1 mg/L) with no effect on expression
profile (data not shown). This finding is in agreement with those
of Jia et al. (2000). This treatment was therefore not continued.
Tissue was harvested by filtration after either 1 or 24 h further
growth at 23 °C with shaking (220 r.p.m.). Filtered tissue was
snap frozen in liquid nitrogen and stored at –80 °C.
RNA extraction and microarray hybridization and 
scanning
Protocols for RNA extraction and microarray hybridization
were essentially those described by Keon et al. (2005b) with
some modification. Total RNA was extracted from freeze-dried
M. graminicola tissue with TRIZOL reagent (Invitrogen, Carlsbad,
CA) following the manufacturer’s protocol. A subsequent over-
night incubation of extracts in 4 M lithium chloride was used to
purify RNA further. Labelling of isolated total RNA with reactive
Alexafluor dyes was carried out using the Superscript Indirect
cDNA Labelling System (Invitrogen) following the recommended
protocol. Twenty micrograms of total RNA was used in each label-
ling reaction. Samples were labelled with either Alexafluor 555
(equivalent to Cy3) detected in the green channel, or Alexaflour
647 (equivalent to Cy5) detected in the red channel. Hybridiza-
tion and washing steps were as outlined at the COGEME website
(http://www.cogeme.man.ac.uk). Details of the M. graminicola
microarray, including quality control experiments previously
carried out, are described by Keon et al. (2005a,b). The annotated
unigene set represented on the microarray is also available at
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the Phytopathogenic Fungi and Oomycete EST Database (http://
cogeme.ex.ac.uk/). Microarray slides were scanned using an
Axon 4000B (Axon Instruments, Foster City, CA) scanner with a
spot size of 5 µm. Preliminary analysis of the data output using
GenePix software (Axon Instruments) was used to optimize
scanning parameters.
Microarray data analysis
Output data were analysed using the methods described by Keon
et al. (2005b) with the exception that eight replicates (four repli-
cates of two repeat experiments) of GenePix results files were
analysed to determine constitutive gene expression differences
between IPO323 and G303, and to compare expression data
after 24 h of epoxiconazole exposure to untreated samples for
both IPO323 and G303. Microarray data were normalized by per
spot and per chip intensity-dependent (Lowess) normalization.
Up- and down-regulated transcripts were determined by filtering
on confidence at a t-test P value of 0.01 using the Benjamini and
Hochberg multiple testing correction. Only genes with transcript
levels differing two-fold or more were considered as differentially
expressed. Blastx searches against the NCBI GenBank fungal
genome database were used to verify annotations of differen-
tially expressed genes.
Hierarchical clustering
Ratios of fluorescence (green/red) signals from eight replicate
experiments after 24 h of epoxiconazole exposure, and four rep-
licate experiments after 1 h of exposure (IPO323 treated/IPO323
untreated, and G303 treated/G303 untreated) were subtracted
from fluorescent data generated for untreated IPO323. Data were
logged to base two and stored in tab-delimited form. Cluster 3.0
(Eisen et al., 1998) was used to cluster data hierarchically using
a Euclidean similarity matrix and the average-linkage clustering
algorithm. TreeView 1.0.13 was used to view the output files from
the clustering process. Blastx searches against the NCBI GenBank
fungal genome database were used to verify annotations of
genes emerging from cluster analyses.
Quantitative RT-PCR analysis
Five micrograms of total RNA was reversed transcribed with
oligo(dT)20 using the SuperScript III First Strand Synthesis System
(Invitrogen) according to the supplier’s instructions. Quantitative
RT-PCR reactions were carried using the SYBR Green Jumpstart
Taq Ready Mix for Quantitative PCR (Sigma). cDNAs were diluted
(1 : 10) and 5 µL used in a 25-µL reaction together with 0.25 µM
of each primer (Table 5). Thermal cycling conditions were as per
the manufacturer’s recommendations, with an annealing temper-
ature of 56 °C. Reactions were carried out on the ABI 7500 Real
Time PCR System (Applied Biosystems) and data analysed using
the 7500 SDS software (version 1.2.1, Applied Biosystems). All
reactions were carried out in triplicate. Relative transcript
abundances were calculated using the 2-[∆][∆]Ct method (Muller
et al., 2002) with beta-tubulin as the endogenous control and
untreated IPO323 as the calibrator sample. Data shown are the
mean relative transcript abundances of two replicate experiments
with standard deviations.
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